| Literature DB >> 36247388 |
Isabel C Hostettler1,2, Vicki M Butenschoen1, Bernhard Meyer1, Sandro M Krieg1, Maria Wostrack1.
Abstract
Introduction: Spinal cord herniation (SCH) is a rare cause of progressive myelopathy and Brown-Séquard-Syndrome. Research question: Evaluation of functional outcome after SCH treatment compared to conservatively treated patients. Material and methods: We retrospectively analysed functional outcome in SCH patients treated between 2009 and 2020. We conducted a systematic search using PubMed, MEDLINE and EMBASE to perform a pooled analysis in SCH patients.Entities:
Keywords: Brown-Séquard-Syndrome; Functional outcome; Myelon herniation; Myelopathy; Spinal cord herniation; Surgery
Year: 2021 PMID: 36247388 PMCID: PMC9560695 DOI: 10.1016/j.bas.2021.100305
Source DB: PubMed Journal: Brain Spine ISSN: 2772-5294
Fig. 1PRISMA patient flow diagram.
Fig. 2Preoperative MR scan with sagittal and axial T2 sequence.
Fig. 3A) Exposure of the spinal cord after opening of the dura and visualisation of the asymmetry by anterior dislocation due to the myelon herniation. B) Exposure of the anteriorly located defect upon retraction of the myelon. C) Retraction of the denticulate ligament and repositioning of the myelon. D) Coverage of the herniation defect with TachoSil via inlay/onlay technique.
Characteristics of hospital-based cohort of surgically treated patients with SCH.
| Patient | Age | Sex | Location of herniation | Symptoms at presentation | Duration of symptoms (months) | Surgical approach | JOA preop | JOA postop | JOA on FU | Symptoms on FU |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 49 | M | Th7/8 | BSS | 144 | Laminoplasty | 12.5 | 12.5 | 12.5 | Stable |
| 2 | 59 | F | Th7/8 | SMP | 18 | Hemilaminectomy | 12 | 12.5 | 14 | Improved |
| 3 | 67 | M | Th1 | Dysesthesia, unrelated pain | 24 | Hemilaminectomy | 16.5 | 16.5 | 16.5 | Stable |
| 4 | 72 | F | C6 | Myelopathy, related pain | 36 | Hemilaminectomy | 12 | 14 | 14 | Improved |
| 5 | 55 | F | Th7/8 | Hypaesthesia, ataxia, unrelated pain | 18 | Hemilaminectomy | 12.5 | 12.5 | 12.5 | Stable |
| 6 | 38 | F | Th6/7 | BSS, unrelated pain | 48 | Laminectomy | 12.5 | 13 | 13 | Improved |
| 7 | 79 | F | L2 | BSS, related pain | 20 | Hemilaminectomy | 13 | 15.5 | 15.5 | Improved |
| 8 | 20 | M | Th5 | SMP | 17 | Hemilaminectomy | 16 | 16 | 16 | Stable |
| 9 | 58 | F | C3/4 | Myelopathy | 4 | Laminectomy | 6 | 4 | 4 | Deteriorated |
BSS = Brown-Séquard-Syndrome; SMP = spastic monoparesis; SPP = spastic paraparesis.
Characteristics of hospital-based cohort of conservatively treated patients with SCH.
| Patient | Age | Sex | Location of herniation | Symptoms at presentation | Duration of symptoms (months) | JOA first presentation | JOA on FU | Symptoms on FU |
|---|---|---|---|---|---|---|---|---|
| 1 | 53 | F | Th6 | Related Pain | 5 | 17 | 17 | Improved |
| 2 | 62 | M | Th2 | Unrelated Pain = incidental | 24 | 16 | Not available | Not available |
| 3 | 58 | M | Th5 | Unrelated Pain = incidental | 84 | 17 | 14 | Deteriorated |
| 4 | 58 | F | Th3 | Incidental | 1 | 16 | 11 | Deteriorated |
| 5 | 43 | M | Th5/6 | Incidental | 0 | 16 | 17 | Improved |
| 6 | 55 | F | Th5/6 | Related Pain, hypaesthesia | 1.4 | 14 | 14 | Deteriorated |
| 7 | 18 | F | Th4-9 | Unrelated Pain = incidental | 6 | 17 | 17 | Improved |
| 8 | 41 | M | Th2/3 | Diffuse Pain, hypaesthesia | 12 | 14.5 | 14.5 | Stable |
Difference between surgically and conservatively treated patients.
| Univariable analysis | |||
|---|---|---|---|
| OR | 95%CI | p-value | |
| Age | 1.03 | 0.96–1.1 | .38 |
| Sex | 0.5 | 0.07–3.55 | .49 |
| Symptom duration | 1.02 | 0.98–1.06 | .31 |
| JOA score first seen | 0.39 | 0.18–0.87 | .02 |
| JOA score on follow-up | 0.78 | 0.48–1.26 | .3 |
Fig. 4Comparison of symptom improvement, deterioration and stability of surgically and conservatively treated patients.
Characteristics of studies included in pooled analysis of spinal cord herniation (SCH).
| Study | surgically treated patients (N) | F Sex, N(%) | Mean age (y, SD) | Mean disease duration (mt, SD) | Symptoms | Loc | preOP JOA score (SD), n | Postop JOA score | FU mt | Improved |
|---|---|---|---|---|---|---|---|---|---|---|
| Ando K ( | 7 | 5 (71.4) | 54.1 (9.4) | 24.4 (42.3) | Thoracic Myelopathy | 7/7 Th | 3.4 (1.5), 7 | 5.9 (2) | N/A | N/A |
| Menon D ( | 1 | 3 (37.5) | 36 (N/A) | 69.4 (8.5) | 2 BSS, 4 spastic paraparesis, 1 radiculopathy, 1 girdle sensation and funicular pain | 6/8 Th, 2/8 C | 8 (2.1), 4/8 | 2/4 improved, 2/4 stable (1 non op) | 19.4 (22.2) | 1/1 |
| Herring EZ ( | 5 | 3 (60) | 63.2 (10.8) | 16.2 (6.5) | 4 BSS, 1 spastic paraparesis | 5/5 Th | 10.9 (2) | 12.5 (2.5) | 26.2 (18) | 4/5 |
| Bartels RHMA ( | 9 | 5 (55.6) | 51.6 (6.1) | 49.8 (30.9) | 2/9 BSS | 9/9 Th | 14.5 (0), 2/9 | N/A | N/A | 5/9, 1/9 deter |
| Gaudino S ( | 12 | 8 (66.7) | 46 (8) | N/A | N/A | N/A | 6.5 (N/A) | mJOA 8 (N/A) | 93.6 (N/A) | 9/12 |
| Carter BJ ( | 7 | 19 (51) | 57 (14.3) | 17 (49) | Neck pain 70%, BSS 5 pat (13%) | 37/37 | N/A | N/A | N/A | 4/7, 1/7 deter |
| Berg-Johnsen J ( | 7 | 6 (85.7) | 57.3 (10.6) | 53.7 (29.3) | 3 SPP, 4 BSS | 7/7 Th | mJOA 6.6 (1.2) | mJOA 8 (1.9) | 12 (0) | 5/7 |
| Hawasli AH ( | 5 | 4 (80) | 42.8 (8.9) | 14.4 (12) | 4 BSS, 1 SPP | 4 Th, 1 C | 13.1 (2) | 15.5 (1.5) | 8.3 (6.7) | 5/5 |
| Prada F ( | 12 | 7 (58.3) | 47.1 (13.7) | 31.3 (16.5) | 2 SPP, 5 BSS, 5 hemi LE 5 | 12 Th | N/A | N/A | 31.7 (21.5) | 12/12 |
| Batzdorf U ( | 10 | 3 (30) | 47.5 (10) | 87.4 (80.6) | 9 SPP or BSS 1 sensory disturb | 10 Th | N/A | N/A | N/A | 5/10 |
| Nakamura M11 | 16 | 9 (56.3) | 55.5 (11.5) | 54.4 (45.9) | 11 BSS, 9 parapleg | 16 Th | 5.1 (1.5) | 7.4 (2.5) | N/A | 15/16 |
| Imagama S ( | 12 | 7 (58.3) | 58.1 (10.4) | 69 (53.7) | 5 BSS, 1 parapar, 7 one sided sy | 12 Th | 5.3 (1.9) | 8.1 (1.9) | 74 (40.1) | 12/12 |
| Hassler W ( | 10 | 7 (70) | 47.7 (5.5) | 45.2 (26) | 4 BSS, 3 pain, 2 para, 1 ataxia | 10 Th | No | N/A | 61.3 (35.4) | 6/10, 1 deter |
| Parmar H ( | 5 | 5 (38.5) | 49 (12.3) | N/A | 7 BSS, 5 SPP, 1 monopar | 13 Th | N/A | N/A | N/A | 4/5 |
| Barrenechea I ( | 7 | 4 (57.1) | 53.7 (14.1) | 42.1 (24.6) | 5 BSS, 1 ASIA D, 1 ASIA C | 7 Th | N/A (ASIA) | N/A | 49.3 (42.8) | 3/7 |
| Maira G ( | 5 | 4 (80) | 47.4 (9.1) | 112 (90.9) | 2 BSS, 2 SPP, 1 hypaesthesia | 5 Th | N/A | N/A | 79.2 (54) | 5/5 |
| Massicotte EM ( | 4 | 5 (62.5) | 44.9 (11.2) | 68.6 (44.3) | 3 SPP, 2 myelop, 2 only sensory | 8 Th | 14.6 (0.8) | N/A | 41.5 (32.8) | 2/4, 1 deter |
| WataN/Abe M18 | 9 | 7 (77.8) | 56 (11.1) | 48 (12.6) | 6 BSS, 3 PP | 9 Th | N/A | N/A | 44.8 (53.7) | 8/9 |
BSS = Brown-Séquard-Syndrome; F = Female; Mt = months; N/A = not applicable, information not available; PP = paraparesis; SD = standard deviation; SPP = spastic paraparesis.
Predictors of improved outcome after surgical treatment of patients with myelon herniation.
| Univariable analysis | Multivariable analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95%CI | p-value | OR | 95%CI | p-value | |
| Mean Age | 1.03 | 0.96–1.11 | .4 | 1.04 | 0.94–1.14 | .57 |
| Female Percentage | 8.1 | 0.94–70.28 | .06 | 2.92 | 0.01–11191.2 | .73 |
| Mean disease duration | 1 | 0.98–1.02 | .85 | |||
| Preoperative JOA score | 0.84 | 0.73–0.97 | .02 | 0.86 | 0.74–0.99 | .04 |